Prognostic implications of troponin T variations in inherited cardiomyopathies using systems biology

Area of Science:

• Cardiovascular Genetics
• Systems Biology
• Molecular Cardiology

Background:

• Cardiac troponin T (TNNT) variations are crucial for prognostication in patients with familial cardiomyopathy and sudden cardiac death risk.
• Disparities in patient outcomes necessitate advanced methods for risk stratification and management.
• Understanding the impact of genetic variations on protein interactions is key to improving clinical prognosis.

Purpose of the Study:

• To investigate the impact of cardiac troponin T variations on intermolecular interactions within the thin filament complex.
• To develop and apply an unbiased systems biology model for analyzing the functional, structural, and physico-chemical consequences of these variations.
• To integrate genomic and structural data with clinical outcomes for enhanced risk stratification in familial cardiomyopathy.

Main Methods:

• Development of a novel, unbiased dynamic model to analyze genetic variations in troponins.
• Integration of the dynamic model with clinical data from a systematic review of 106 articles on familial cardiomyopathy.
• Analysis of 136 disease-causing variations across 981 clinical cases.
• Survival analysis comparing high-risk (regions 90-129, 130-180) and low-risk (regions 1-89, 200-288) variation regions.

Main Results:

• Identified distinct pathogenic hotspots for dilated and hypertrophic cardiomyopathies.
• Cardiac troponin T variations in regions 90-129 and 130-179 were associated with worse survival, particularly concerning sudden cardiac death.
• Region 90-130 emerged as a hotspot for sudden cardiac death, while region 131-179 was linked to heart failure death/transplantation outcomes, predominantly in dilated cardiomyopathy.
• Survival analysis showed significant differences between high-risk and low-risk regions for both sudden cardiac death (p=0.011) and heart failure death/transplant (p=0.028).

Conclusions:

• The study highlights specific regions of cardiac troponin T as critical determinants of clinical outcomes in familial cardiomyopathy.
• The integrative approach combining genomic, structural, and clinical data provides a powerful framework for understanding genotype-phenotype correlations.
• Findings have implications for refining clinical genomics methodologies and improving risk stratification strategies for patients at risk of sudden cardiac death and heart failure.